![Charles Legg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Legg
Geschäftsführer bei CureLab Oncology, Inc.
Profil
Charles Legg currently works at Secular Student Alliance, as Director from 2021, ZEA Biosciences Corp., as Chief Operating Officer, and CureLab Oncology, Inc., as Chief Operating Officer.
Aktive Positionen von Charles Legg
Unternehmen | Position | Beginn |
---|---|---|
CureLab Oncology, Inc.
![]() CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Geschäftsführer | - |
ZEA Biosciences Corp.
![]() ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | Geschäftsführer | - |
Secular Student Alliance | Direktor/Vorstandsmitglied | 01.01.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
CureLab Oncology, Inc.
![]() CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
ZEA Biosciences Corp.
![]() ZEA Biosciences Corp. Agricultural Commodities/MillingProcess Industries Zea Biosciences Corp. engages in agriculture banking and financial services. The company was founded in 2018 and is headquartered in Walpole, MA. | Process Industries |
Secular Student Alliance |